No download available
Effectiveness of mepolizumab in eosinophilic asthma and chronic rhinosinusitis with nasal polyps
Volume: 0 - Issue: 0
First page: 0 - Last page: 0
E. Chiner - I. Boira - J.L. Lafuente - M. Antón - M.A. Bernabeu - P. Fernández - V. Esteban - M. Llombart
DOI: 10.4193/Rhin26.207
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory disease affecting 2–4% of the population which has a significant impact on quality of life. Approximately 40% to 60% of people with CRSwNP also have eosinophilic asthma, reflecting the unified airway concept characterised by type 2 inflammation driven by interleukin (IL)-4, IL-5 and IL-13.
Rhinology 0 - 0: 0-0, 0000
To see the issue content and the abstract you do not have to login
Please login to download the full articles
If you do not have a subscription to Rhinology please consider taking one.
